US study reveals Co-STAR receptor cells show promise in treating cancers
The most globally prevalent cancers include breast, lung, bowel and prostate cancers
Read More
Author: Jen Brogan
KCL leads first guidelines on immune monitoring for hard-to-treat blood cancer
Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK
Read More
Study finds Parkinson’s disease SLT more effective than one used in NHS
The progressive neurodegenerative condition affects around 153,000 people in the UK
Read More
Trial finds over-the-counter nasal sprays could reduce RTIs and antibiotic use
Affecting parts of the body involving breathing, RTIs impact one in five people in England
Read More
NIHR and Diabetes UK invest nearly £3m to prevent and treat diabetes distress
Almost 50% of adults living with type 1 diabetes experience high levels of diabetes distress
Read More- FDA approves new high dose Spinraza regimen for SMA
- Viridian reports positive results from elegrobart phase 3 trial
- Cure Parkinson’s convenes expert panel to assess £2 million combination therapy funding call
- Kygevvi approved in Europe as first treatment for TK2d
- Tozorakimab shows significant benefit in two major COPD trials
